Abstract
Intrauterine blood transfusion is the mainstay of managing foetuses with severe anemia. It may however result in fetomaternal hemorrhage, which in cases of Rh isoimmunisation may increase the severity of the disease by enhancing the maternal immunological response to fetal antigens. This study was conducted to determine the frequency, specificity and origin of additional red cell antibodies which developed after IUT. The change in the titre of allo anti-D following IUT was also determined. Antibody detection and titration was done on the blood samples of all the patients before and after intrauterine blood transfusion to check for the development of additional antibody and change in the titre of existing anti-D. Severe anemia was found in 17 (58.6 %) fetuses who received a total of 42 ultrasound-guided IUTs. Development of antibodies additional to anti-D in maternal serum was seen in 5 (29.4 %) cases. The specificity of additional alloantibodies was anti-C in four cases whereas it was anti-E in one case. Four fold or greater increase in existing allo-anti D titre was seen in 6 (35.3 %) cases after IUT. Enhancement of maternal sensitisation leading to an increase in maternal antibody titre is particularly seen after the first IUT. Matching of the donor RBCs particularly for Rh antigens might prevent the induction of additional alloantibodies against these antigens. IUT as a treatment modality should be given judiciously and only when the need is inevitable.
This is a preview of subscription content, log in via an institution to check access.
References
Verduin EP, Schonewille H, Brand A et al (2013) High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother–child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation. Transfusion 53:939–947
van Kamp IL (2004) Review of the literature on red cell alloimmunization in pregnancy. Kluwer, Dordrecht
Watson WJ, Wax JR, Miller RC, Brost BC (2006) Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. Am J Perinatol 23:189–192
Hoch J, Giers G, Bald R, Hansmann M, Hanfland P (1993) Antibody induction after intrauterine interventions. Infusionsther Transfusionsmed 20(Suppl 2):70–73
Hoch H, Giers G, Bald R, Hanfland P (1992) Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis. Beitr Infusionsther 30:439–442
Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A (2007) High additional maternal red cell alloimmunization after Rhesus and K matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 196:1–6
Nicolini U, Kochenour NK, Greco P et al (1988) Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ 297:1379–1381
Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC (2007) Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 110:2736–2743
Hendrickson JE, Desmarets M, Deshpande SS et al (2006) Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 46:1526–1536
Vietorh HE, Kanhai HH, Brand A (1994) Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion 34:970–974
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dubey, A., Sonker, A. & Chaudhary, R. Enhancement of Antibody Titre and Development of Additional Red Cell Alloantibodies Following Intrauterine Transfusion. Indian J Hematol Blood Transfus 32, 92–94 (2016). https://doi.org/10.1007/s12288-013-0308-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-013-0308-6